US Patent 10647730 Macrocyclic compounds as TRK kinase inhibitors
Patent 10647730 was granted and assigned to Array Biopharma Inc. on May, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 20, 2018
Date of Patent
May 12, 2020
Patent Applicant
Patent Application Number
15900019
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10647730 Macrocyclic compounds as TRK kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
